These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9636491)

  • 1. Role of acute rejection in chronic rejection.
    Vanrenterghem Y
    Transplant Proc; 1998 Jun; 30(4):1210-1. PubMed ID: 9636491
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk factors for acute rejection in 806 cyclosporine-treated renal transplants: a multivariate analysis.
    Mota A; Figueiredo A; Cunha MF; Bastos M; Pratas J; Furtado L
    Transplant Proc; 2003 May; 35(3):1061-3. PubMed ID: 12947856
    [No Abstract]   [Full Text] [Related]  

  • 3. The treatment of chronic rejection with mycophenolate mofetil versus azathioprine in kidney transplantation.
    Jirasiritham S; Sumethkul V; Mavichak V; Chalermsanyakorn P
    Transplant Proc; 2000 Nov; 32(7):2040-2. PubMed ID: 11120057
    [No Abstract]   [Full Text] [Related]  

  • 4. Increasing incidence of steroid resistant rejection in kidney transplantation.
    Arrazola L; Sozen H; Humar A; Papalois V; Uknis M; Matas AJ
    Transplant Proc; 2000 Nov; 32(7):1767. PubMed ID: 11119926
    [No Abstract]   [Full Text] [Related]  

  • 5. Allograft instability with frequent acute rejections and early chronic transplant glomerulopathy related to suboptimal doses of cyclosporine A.
    Savin M; Petronic V; Djukanovic L; Dujic A; Stojkovic D; Sindjic M
    Transplant Proc; 1997 Nov; 29(7):2977-9. PubMed ID: 9365636
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute rejection episodes predict long-term renal transplantation survival.
    Kokado Y; Takahara S; Hatori M; Ichimaru I; Wang JD; Miki T; Okuyama A
    Transplant Proc; 1997; 29(1-2):1537-40. PubMed ID: 9123416
    [No Abstract]   [Full Text] [Related]  

  • 7. Is sensitivity to cyclosporine influenced by the HLA-DR phenotype of kidney graft recipients?
    Kyriakopoulos G; Antoniadis A; Gakis D; Papanikolaou V
    Transplant Proc; 1996 Dec; 28(6):3294-5. PubMed ID: 8962278
    [No Abstract]   [Full Text] [Related]  

  • 8. Accelerated acute rejection in renal allograft.
    Han DJ; Yoon HS; Lee HM
    Transplant Proc; 1996 Jun; 28(3):1455. PubMed ID: 8658738
    [No Abstract]   [Full Text] [Related]  

  • 9. Prospective randomized study comparing FK 506 (Prograft) and cyclosporine A (Neoral) as primary immunosuppression in cadaveric renal transplants at a single institution: interim report of the first 80 cases.
    Morris-Stiff G; Singh J; Ostrowski K; Balaji V; Moore R; Darby C; Lord R; Jurewicz WA
    Transplant Proc; 1998 Jun; 30(4):1295-6. PubMed ID: 9636525
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparative analysis of methyl prednisone pulse versus orthoclone therapy in the management of acute cellular rejection.
    Nampoory MR; Johny KV; Costandi JN; al-Muzairai IM; Gupta RK; Nair MP; Samhan M; al-Mousawi M
    Transplant Proc; 1997 Nov; 29(7):2967-70. PubMed ID: 9365632
    [No Abstract]   [Full Text] [Related]  

  • 11. Tacrolimus versus cyclosporine as primary prophylactic therapy after cadaveric renal transplant: two-year survival study.
    Wong KM; Cheung CY; Chan YH; Chak WL; Choi KS; Chau KF; Li CS
    Transplant Proc; 2000 Nov; 32(7):1721-2. PubMed ID: 11119907
    [No Abstract]   [Full Text] [Related]  

  • 12. Twenty-six year surgical experience of 259 pediatric transplants in 235 children and long-term follow-up of 181 under cyclosporine therapy.
    Berardinelli L; Ferraresso M; Raiteri M; Carini M; Vegeto A
    Transplant Proc; 1998 Aug; 30(5):1977-9. PubMed ID: 9723359
    [No Abstract]   [Full Text] [Related]  

  • 13. Pediatric renal transplantation: personal experience.
    Berloco P; Pretagostini R; Poli L; Rossi M; Iappelli M; Di Nicuolo A; Venettoni S; De Simone P; Cancrini C; Novelli G; Alfani D; Cortesini R; Lubrano R; Castello MA
    Transplant Proc; 1996 Feb; 28(1):282-3. PubMed ID: 8644225
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk factors for chronic graft dysfunction in 918 renal transplants.
    Mota A; Figueiredo A; Macário F; Cunha FX; Freitas L; Parada B; Bastos C; Furtado L
    Transplant Proc; 2003 May; 35(3):1064-5. PubMed ID: 12947857
    [No Abstract]   [Full Text] [Related]  

  • 15. Conversion at first rejection: a prospective trial comparing cyclosporine microemulsion with tacrolimus in renal transplant recipients.
    Dudley CR;
    Transplant Proc; 2001; 33(1-2):1034-5. PubMed ID: 11267179
    [No Abstract]   [Full Text] [Related]  

  • 16. Early graft dysfunction developed within one week after renal allograft.
    Kim SC; Jang HJ; Kim SK; Kim TH; Yoo ES; Jung JG; Han DJ
    Transplant Proc; 2000 Nov; 32(7):1886-7. PubMed ID: 11119985
    [No Abstract]   [Full Text] [Related]  

  • 17. Kidney transplantation from living donors in Hungary: experience of 22 years.
    Perner F; Hidvégi M; Járay J; Alföldy F; Gyódi E; Petrányi G
    Transplant Proc; 1996 Dec; 28(6):3584-90. PubMed ID: 8962389
    [No Abstract]   [Full Text] [Related]  

  • 18. Chagas disease and transplantation.
    Vazquez MC; Sabbatiello R; Schiavelli R; Maiolo E; Jacob N; Pattin M; Rearte A
    Transplant Proc; 1996 Dec; 28(6):3301-3. PubMed ID: 8962281
    [No Abstract]   [Full Text] [Related]  

  • 19. Analysis of 160 consecutive living unrelated kidney transplants: 1983-1997.
    Alfani D; Pretagostini R; Rossi M; Poli L; De Simone P; Colonnello M; Novelli G; Urbano D; Venettoni S; Persijn G; Smits J; Cortesini R
    Transplant Proc; 1997 Dec; 29(8):3399-401. PubMed ID: 9414764
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclosporine-related hemolytic-uremic syndrome in kidney graft recipients: clinical and histomorphologic evaluation.
    Bren AF; Kandus A; Buturovic J; Koselj M; Kaplan Pavlovcic S; Ponikvar R; Kovac D; Lindic J; Vizjak A; Ferluga D
    Transplant Proc; 1998 Jun; 30(4):1201-3. PubMed ID: 9636487
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.